SBI Securities’s Genprex GNPX Stock Holding History

SBI Securities’s Portfolio GNPX Stock Details GNPX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$23	Buy	8 +6	+300%	+$35	﹤0.01%	3892
2026 Q2	$25	Hold	2	–	–	﹤0.01%	3807
2026 Q1	$87	Hold	2	–	–	﹤0.01%	3446
2025 Q4	$84	Hold	2	–	–	﹤0.01%	3458
2025 Q3	$410	Hold	2	–	–	﹤0.01%	3050
2025 Q2	$552	Hold	2	–	–	﹤0.01%	2928
2025 Q1	$599	Buy	+2	New	+$1.11K	﹤0.01%	2795
2024 Q4	–	Hold	0	–	–	–	2963

SBI Securities's GNPX Position: Q3 2026 in Review

SBI Securities increased its Genprex (GNPX) stake by 300% in Q3 2026, buying an estimated $35 and bringing the position to 8 shares worth $23. The position accounts for ﹤0.01% of the portfolio, ranked #3892.

SBI Securities first reported a position in GNPX in Q1 2025 and has held it in 7 quarters since. The position peaked at $599 in Q1 2025. 2 funds tracked by Wall St. Rank hold GNPX as of Q3 2026.

SBI Securities held 8 shares of Genprex worth $23 as of Q3 2026.
SBI Securities bought 6 Genprex shares in Q3 2026, an estimated $35.
Genprex made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #3892 holding.
SBI Securities first reported a position in Genprex in Q1 2025 and has held it in 7 quarters since.
SBI Securities's Genprex position peaked at $599 in Q1 2025.
2 funds tracked by Wall St. Rank held Genprex as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.